U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Search Current & Recent Grants > Biomarker-Guided Evaluation of Glycated Testing Modalities for Dysglycemia among Persons Living with HIV (BEGET) Print

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov​.

Biomarker-Guided Evaluation of Glycated Testing Modalities for Dysglycemia among Persons Living with HIV (BEGET)

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

HIV-associated Noncommunicable Diseases Research at LMIC Institutions

Project Information in NIH RePORTER

Biomarker-Guided Evaluation of Glycated Testing Modalities for Dysglycemia among Persons Living with HIV (BEGET)

Principal Institution

University of Maryland Baltimore

Principal Investigator(s) (PI)

Jumare, Jibreel

Project Contact Information

Email: jibreel.jumare@ihv.umaryland.edu

Year(s) Awarded

2023-2025

Country

Nigeria

Collaborators

University of Abuja Teaching Hospital

Project Description

The glycosylated hemoglobin (HbA1c) test is considered highly valuable for early detection of diabetes but is currently not recommended for use among people living with HIV (PLHIV) due to their lower hemoglobin levels. This study will identify appropriate HbA1c diagnostic thresholds for strata of hemoglobin and markers of inflammation, insulin resistance, and immuno-virologic status, in addition to evaluating an alternative glycated test, fructosamine, with no hemoglobin limitation. Findings will inform the development of guidelines for the optimal use of glycated testing tools among PLHIV and others with low hemoglobin in the general population.

Related World Regions / Countries

Related Global Health Research Topics